🎙️ This week on the #BioCenturyThisWeek podcast, BioCentury editors analyze key challenges facing biotech and investors: ➣ FDA Turmoil: How leadership changes, staffing cuts and reorganization are increasing risks for biotech ➣ Trade War Fallout: The impact of new tariffs on the sector and investment strategies ➣ #AACR25 Preview: Insights into VEGF-targeted bispecifics ahead of the annual cancer research meeting ➣ Market Outlook: Strategies for navigating a bear market, with insights from BioCentury's 2Q25 Financial Markets Preview (https://lnkd.in/gMU7MeT5) 🎧 Tune in on Spotify, Apple Podcasts, YouTube or your favorite podcast platform: https://lnkd.in/gJVDyjBA Thank you to the sponsor of this episode, RemeGen荣昌生物 / RemeGen Biosciences.
